News

Chris Roe, Principal Research Fellow, and Ricardo Diaz de Leon Ortega, Modelling and Simulation Research Fellow, attended and presented at the Basic Biopharmaceutics Workshop hosted by The Biopharmaceutics Focus Group of the Academy of Pharmaceutical Sciences UK in London.

Dr. Dolly Jacob, Director of Integrated Development Services at Quotient Sciences featured in Drug Development & Delivery looking at the challenges of solubility & bioavailability.

Stephen Byard shares his thoughts with Pharmaceutical Technology on the strategies we use for streamlining small molecule formulation development when bridging from candidate selection to first-in-human clinical testing.

An expansion of our early-phase formulation development capabilities for oral dosage forms at our Nottingham, UK, facility builds upon our existing formulation capabilities.

Andy Lewis, Vice President, Pharmaceutical Sciences, has written an article for Drug Development & Delivery entitled, "Alternative Strategies for Development of Modified-Release Dosage Forms"

John McDermott, Quotient Sciences' Executive Drug Development Consultant, discusses Integrated Development Strategies Overcome Solubility Challenges, in Drug Development & Delivery's Special Feature.